Control of telomere length by the human telomeric protein TRF1
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Human telomeres, the nucleoprotein complexes at chromosome ends, consist of tandem arrays of TTAGGG repeats bound to specific proteins. In normal human cells, telomeres shorten with successive cell divisions, probably due to the terminal sequence loss that accompanies DNA replication. In tumours and immortalized cells, this decline is halted through the activation of telomerase, a reverse transcriptase that extends the telomeric TTAGGG-repeat arrays. Telomere length is stable in several immortal human-cell lines, suggesting that a regulatory mechanism exists for limiting telomere elongation by telomerase. Here we show that the human telomeric-repeat binding factor TRF1 (ref. 8) is involved in this regulation. Long-term overexpression of TRF1 in the telomerase-positive tumour-cell line HT1080 resulted in a gradual and progressive telomere shortening. Conversely, telomere elongation was induced by expression of a dominant-negative TRF1 mutant that inhibited binding of endogenous TRF1 to telomeres. Our results identify TRF1 as a suppressor of telomere elongation and indicate that TRF1 is involved in the negative feedback mechanism that stabilizes telomere length. As TRF1 does not detectably affect the expression of telomerase, we propose that the binding of TRF1 controls telomere length in cis by inhibiting the action of telomerase at the ends of individual telomeres.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TRF1 can serve to modulate telomere length, but it also serves to facilitate DNA replication through the telomere repeats, which acts as fragile DNA sites (5)(6)(7).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [5]
In the citing paper
“TRF1 and TRF2 bind the double-stranded telomere.”
From Telomeres and telomerase in cancer (2010) · cites this paper as van Steensel,B. et al. (1997)
In the citing paper
“Telomere length in human cells is controlled by a homeostasis mechanism that involves telomerase and the negative regulator of telomere length, TRF1 (TTAGGG repeat binding factor 1).”
From Control of Human Telomere Length by TRF1 and TRF2 (2000) · cites this paper as [44]
In the citing paper
“In this system, TRF1 did not affect the activity of telomerase detectable in cell extracts, suggesting that TRF1 does not affect telomerase activity globally in the cell.”
From Control of Human Telomere Length by TRF1 and TRF2 (2000) · cites this paper as [44]
In the citing paper
“Conversely, the expression of a dominant negative allele of TRF1, which removes endogenous TRF1 from telomeres, leads to telomere elongation.”
From Control of Human Telomere Length by TRF1 and TRF2 (2000) · cites this paper as [44]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
Morin, G. B. (1989) · Cell · doi:10.1016/0092-8674(89)90035-4 · Cited by 1,495
Structure and variability of human chromosome ends.
de Lange, T., Shiue, L., Myers, R. M., Cox, D. R., Naylor, S. L., Killery, A. M., & Varmus, H. E. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.2.518 · Cited by 848
Progress towards a quantitative understanding of Antarctic ozone depletion
Solomon, S. (1990) · Nature · doi:10.1038/347347a0 · Cited by 734
Chong, L., van Steensel, B., Broccoli, D., Erdjument-Bromage, H., Hanish, J., Tempst, P., & de Lange, T. (1995) · Science · doi:10.1126/science.270.5242.1663 · Cited by 694
Cited by
Items 701–800 of 1,000
G-quadruplex-mediated regulation of telomere binding protein POT1 gene expression
He, Q., Zeng, P., Tan, J., Ou, T., Gu, L., Huang, Z., & Li, D. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.03.001 · Cited by 26
Kaizer, H., Connelly, C. J., Bettridge, K. E., Viggiani, C. J., & Greider, C. W. (2015) · Genetics · doi:10.1534/genetics.115.177899 · Cited by 26
The role of telomere-binding modulators in pluripotent stem cells
Li, F., Ge, Y., Liu, D., & Songyang, Z. (2019) · Protein & Cell · doi:10.1007/s13238-019-0651-y · Cited by 26
Cell‐cycle‐dependent Xenopus TRF1 recruitment to telomere chromatin regulated by Polo‐like kinase
Nishiyama, A., Muraki, K., Saito, M., Ohsumi, K., Kishimoto, T., & Ishikawa, F. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600964 · Cited by 29
Increasing sensitivity to arsenic trioxide-induced apoptosis by altered telomere state
Zhang, Y., Cao, E.-H., Liang, X.-Q., & Qin, J. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02013-2 · Cited by 25
Clonal Heterogeneity in Telomerase Activity and Telomere Length in Tumor-Derived Cell Lines
Savre‐Train, I., Gollahon, L., & Holt, S. E. (2000) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22354.x · Cited by 26
Mao, L. (1997) · Molecular Medicine Today · doi:10.1016/s1357-4310(97)01111-8 · Cited by 25
Mammalian Rap1 widens its impact
Crabbé, L., & Karlseder, J. (2010) · Nature Cell Biology · doi:10.1038/ncb2088 · Cited by 25
Unraveling secrets of telomeres: One molecule at a time
Lin, J., Kaur, P., Countryman, P. J., Opresko, P. L., & Wang, H. (2014) · DNA repair · doi:10.1016/j.dnarep.2014.01.012 · Cited by 26
Yang, S. (2010) · Oncology Reports · doi:10.3892/or_00000955 · Cited by 24
Wallace, H. A., Rana, V., Nguyen, H. Q., & Bosco, G. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28681 · Cited by 27
Age-Related Dysfunctions: Evidence and Relationship with Some Risk Factors and Protective Drugs
Libertini, G., Corbi, G., Cellurale, M. T., & Ferrara, N. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919120034 · Cited by 27
Naked mole rat TRF1 safeguards glycolytic capacity and telomere replication under low oxygen
Augereau, A., Mariotti, M., Pousse, M., Filipponi, D., Libert, F., Beck, B., Gorbunova, V. A., Gilson, É., & Gladyshev, V. N. (2021) · Science Advances · doi:10.1126/sciadv.abe0174 · Cited by 26
“Within the shelterin complex, TRF1 facilitates a proper progression of the replication fork through the telomeric chromatin (15, 16) and represses telomerase (17).”
BackgroundYamada, K., Yajima, T., Yagihashi, A., Kobayashi, D., Koyanagi, Y., Asanuma, K., Yamada, M., Moriai, R., Kameshima, H., & Watanabe, N. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00915.x · Cited by 24
Telomeres and Essential Hypertension
Aviv, A. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00202-7 · Cited by 28
Aging clock: the watchmaker's masterpiece
Ishikawa, F. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050034 · Cited by 26
Nguyen, D. C., & Crowe, D. L. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00044-5 · Cited by 27
Functional Diversity of Silencers in Budding Yeasts
Sjöstrand, J. O. O., Kegel, A., & Åström, S. U. (2002) · Eukaryotic Cell · doi:10.1128/ec.1.4.548-557.2002 · Cited by 24
“In humans (Trf1) (66), the budding yeasts S.”
Telomere biology in aging and cancer: early history and perspectives
Hayashi, M. (2017) · Genes & Genetic Systems · doi:10.1266/ggs.17-00010 · Cited by 25
TERRA R-loops connect and protect sister telomeres in mitosis
Sze, S., Bhardwaj, A., Fnu, P., Azarm, K., Mund, R., Ring, K., & Smith, S. H. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113235 · Cited by 23
Polonio-Vallon, T., Krüger, D., & Hofmann, T. G. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00148 · Cited by 26
“TRF1 has previously been shown to regulate telomere length (98, 99).”
BackgroundThe levels of telomere-binding proteins in human tumours and therapeutic implications
Cookson, J. C., & Laughton, C. A. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.014 · Cited by 26
Epigenetic Regulation of Telomere Chromatin Integrity in Pluripotent Embryonic Stem Cells
Wong, L. H. (2010) · Epigenomics · doi:10.2217/epi.10.49 · Cited by 23
Mattes, J., Nawroth, J., Boukamp, P., Eils, R., & Greulich‐Bode, K. M. (2006) · IEEE International Symposium on Biomedical Imaging (ISBI) · doi:10.1109/isbi.2006.1625100 · Cited by 23
“The telomere length is regulated by the telomere repeat binding factor 1 (TRF 1), a telomere binding protein [7].”
BackgroundDouble-stranded telomeric DNA binding proteins: Diversity matters
Červenák, F., Juríková, K., Sepšiová, R., Neboháčová, M., Nosek, J., & Tomáška, Ľ. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1356511 · Cited by 24
“TRF1 had an opposite effect, indicating that it is a negative regulator of telomere length.(52) Shortly after the identification of TRF1, the de Lange and”
BackgroundShoeb, M., Mustafa, G. M., Joseph, P., Umbright, C., Kodali, V., Roach, K. A., Meighan, T. G., Roberts, J. R., Erdely, A., & Antonini, J. M. (2019) · Scientific Reports · doi:10.1038/s41598-018-36712-6 · Cited by 23
Deng, W. W., Wu, J., Wang, F., Kanoh, J., Dehé, P.-M., Inoue, H., Chen, J., & Lei, M. (2015) · Cell Research · doi:10.1038/cr.2015.76 · Cited by 23
Telomerase and the Chromosome end Replication Problem
Cech, T. R., & Lingner, J. (2007) · Novartis Foundation symposium · doi:10.1002/9780470515433.ch3 · Cited by 25
PinX1 Localizes to Telomeres and Stabilizes TRF1 at Mitosis
Yonekawa, T., Yang, S., & Counter, C. M. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05641-11 · Cited by 24
“Overexpression of TRF1 in human cells causes telomere shortening (25).”
BackgroundHsu, C., Ko, J., Shai, S., & Lee, L. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.06.019 · Cited by 25
Telomere Structure, Replication and Length Maintenance
Muniyappa, K., & Kironmai, K. M. (1998) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409239891204242 · Cited by 24
Function, replication and structure of the mammalian telomere
Broccoli, D. (2004) · Cytotechnology · doi:10.1007/s10616-004-5120-6 · Cited by 29
Kim, E. S., Ye, Y., Vaporciyan, A. A., Xing, J., Huang, M., Gu, J. H., Roth, J. A., Lippman, S. M., & Wu, X. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000398 · Cited by 24
“elongation.(12,13) POT1 binds the 3′ telomeric overhang and may regulate telomerase access.”
BackgroundNapier, C. E., Veas, L. A., Kan, C.-Y., Taylor, L. M., Yuan, J. J., Wen, V. W., James, A. C., O'Brien, T. A., Lock, R. B., & MacKenzie, K. L. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.06.010 · Cited by 23
Wilson, F. R., Ho, A., Walker, J. R., & Zhu, X. (2016) · Journal of Cell Science · doi:10.1242/jcs.186098 · Cited by 22
Panero, J., Arbelbide, J. A., Fantl, D. B. E., Rivello, H. G., Kohan, D., & Slavutsky, I. R. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00057 · Cited by 22
Expression profile of significant immortalization genes in colon cancer
Witkowska (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000348 · Cited by 22
Telomerase recruitment to telomeres
Stern, J. L., & Bryan, T. M. (2008) · Cytogenetic and Genome Research · doi:10.1159/000167810 · Cited by 25
Matsutani, N., Yokozaki, H., Tahara, E., Tahara, H., Kuniyasu, H., Kitadai, Y., Haruma, K., Chayama, K., Tahara, E., & Yasui, W. (2001) · Pathobiology · doi:10.1159/000055946 · Cited by 25
Lee, J. H., Kim, J. H., Kim, W. T., Kang, B. G., & Chung, I. K. (2000) · Plant Molecular Biology · doi:10.1023/a:1006373917321 · Cited by 22
Yamada, O., Akiyama, M., Kawauchi, K., Adachi, T., Yamada, H., Kanda, N., & Aikawa, E. (2003) · Cell Transplantation · doi:10.3727/000000003108746911 · Cited by 23
Telomeric RNA (TERRA) increases in response to spaceflight and high-altitude climbing
Al-Turki, T. M., Maranon, D. G., Nelson, C. B., Lewis, A. M., Luxton, J. J., Taylor, L. E., Altina, N. H., Wu, F., Du, H., Kim, J., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06014-x · Cited by 23
Swanberg, S. E., & Delany, M. E. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.03.022 · Cited by 23
Normal telomere lengths in young mothers of children with Down's syndrome
Dorland, M., van Montfrans, J. M., van Kooij, R. J., Lambalk, C. B., & Velde, E. R. T. (1998) · The Lancet · doi:10.1016/s0140-6736(05)61516-4 · Cited by 21
A Comprehensive Model for the Recognition of Human Telomeres by TRF1
Garton, M., & Laughton, C. A. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.05.005 · Cited by 23
Aurora Kinase B, a novel regulator of TERF1 binding and telomeric integrity
Chan, F. L., Vinod, B., Novy, K., Schittenhelm, R. B., Huang, C., Udugama, M., Nunez-Iglesias, J., Lin, J. I., Hii, L. L., Chan, J., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx904 · Cited by 21
Potential Telomere-Related Pharmacological Targets
Berei, J., Eckburg, A., Miliavski, E., Anderson, A. D., Miller, R. J., Dein, J., Giuffre, A. M., Tang, D., Deb, S., Racherla, K. S., et al. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200109114339 · Cited by 23
Regulation of PRDX1 peroxidase activity by Pin1
Chu, K. L., Lew, Q. J., Rajasegaran, V., Kung, J. T., Zheng, L., Yang, Q., Shaw, R., Cheong, N., Liou, Y., & Chao, S. (2013) · Cell Cycle · doi:10.4161/cc.23916 · Cited by 21
“Pin1 interacts with the telomeric DNAbinding protein TRF1, a key regulator in telomere maintenance, which inhibits telomere elongation.(13,14) Mice lacking Pin1 display elevated TRF1 levels, telomere loss and a range of premature aging phenotypes.”
BackgroundNishio, Y., Nakanishi, K., Ozeki, Y., Jiang, S., Kameya, T., Hebisawa, A., Mukai, M., Travis, W. D., Franks, T. J., & Kawai, T. (2006) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyl118 · Cited by 21
“Recently, telomerase-specific DNA-binding proteins have been put forward as additional candidates for the molecules modifying telomerase activity ( 34 ,35).”
BackgroundTelomerase: a potential therapeutic target for cancer
Fletcher, T. M. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.3.457 · Cited by 21
“Both telomerase inhibitory proteins, pot1 and PinX1, appear to be in complexes with TRF1 first shown to negatively regulate telomere length [71].”
BackgroundTelomere-length regulation in inter-ecotype crosses of Arabidopsis
Maillet, G., White, C. I., & Gallego, M. E. (2006) · Plant Molecular Biology · doi:10.1007/s11103-006-9061-7 · Cited by 22
“Depletion of TRF1 from telomeres leads to telomere lengthening ( van Steensel and de Lange 1997 ) and overexpression induces telomere shortening (Smogorzewska et al. 2000).”
BackgroundCloning and characterisation of the chicken gene encoding the telomeric protein TRF2
Konrad, J. P., Mills, W. E., Easty, D. J., & Farr, C. J. (1999) · Gene · doi:10.1016/s0378-1119(99)00374-1 · Cited by 21
Wolf, S. E., & Shalev, I. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105261 · Cited by 20
Xin, X., Senthilkumar, P. K., Schnoor, J. L., & Ludewig, G. (2015) · Environmental Science and Pollution Research · doi:10.1007/s11356-015-5187-y · Cited by 20
Habib, I., Khan, S., Mohammad, T., Hussain, A., Alajmi, M. F., Rehman, M. T., Anjum, F., & Hassan, M. I. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1922313 · Cited by 21
“…(Chen et al., 2008) that binds TNKS1 and TNKS2, a specific TRFH dimerization conserved domain that assists the formation of a homodimer between TRF1 – TRF1 structure (Bianchi et al., 1997; Van Steensel & De Lange, 1997) and a Cterminal DNA binding domain (Chen et al., 2008) shown in Figure 2.”
BackgroundThe role of shelterin in maintaining telomere integrity
Longhese, M. P., Anbalagan, S., Martina, M., & Bonetti, D. (2011) · Frontiers in bioscience · doi:10.2741/4014 · Cited by 29
“In humans, TRF1 or TRF2 overexpression causes telomere shortening, whereas a dominant negative form of TRF1 that removes the endogenous TRF1 from telomeres induces progressive telomere elongation (151,152).”
BackgroundTelomere Maintenance as Therapeutic Target in Embryonal Tumours
Shalaby, T., Hiyama, E., & Grotzer, M. A. (2010) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520611009030196 · Cited by 22
“• Pin2 mutant [224, 246-250]”
The Cell Biology of Stem Cells
Meshorer, E., & Plath, K. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7037-4 · Cited by 23
Siddiqa, A., Cavazos, D., & Marciniak, R. A. (2006) · Rejuvenation Research · doi:10.1089/rej.2006.9.378 · Cited by 20
Expression of Telomeric Repeat Binding Factor-1 in Astroglial Brain Tumors
Torre, D. L., DIVITIIS, O. D., Conti, A., Angileri, F. F., Cardali, S. M., Aguennouz, M., Aragona, M., Panetta, S., D’Avella, D., Vita, G., et al. (2005) · Neurosurgery · doi:10.1227/01.neu.0000156468.41461.6f · Cited by 21
“The mutation or deletion of TRF1 can result in telomere elongation and extend cell survival (47).”
BackgroundInfluentialGreene, E. C., Bednenko, J., & Shippen, D. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1544 · Cited by 22
“Single-nucleotide mutations in telomeric repeat sequences impair normal interactions between structural telomere binding proteins and the DNA (22, 41).”
BackgroundDolly, No Longer the Exception: Telomeres and Implications for Transplantation
Shiels, P. G., & Jardine, A. G. (2003) · Cloning and Stem Cells · doi:10.1089/153623003322234768 · Cited by 20
“TRF1, a key telomere binding protein and functional telomerase antagonist is differentially distributed according to cell type (Broccoli et al., 1997; Steensel and de Lange, 1997).”
Tire, B., & Öztürk, S. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01211-4 · Cited by 19
The Drosophila tankyrase regulates Wg signaling depending on the concentration of Daxin
Feng, Y., Li, X., Ray, L., Song, H., Qu, J., Lin, S., & Lin, X. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.04.014 · Cited by 20
Wang, H., Ni, J., Guo, X., Zhou, T., Ma, X., Xue, J., & Wang, X. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.06.063 · Cited by 19
Phosphorylation of Telomeric Repeat Binding Factor 1 (TRF1) by Akt Causes Telomere Shortening
Chen, Y., Teng, S., & Wu, K. (2009) · Cancer Investigation · doi:10.1080/07357900802027081 · Cited by 27
“Overexpression of TRF1 negatively regulates telomere length, leading to genomic instability (10, 11).”
BackgroundDual Disruption of DNA Repair and Telomere Maintenance for the Treatment of Head and Neck Cancer
Lajud, S. A., Nagda, D. A., Yamashita, T., Zheng, J., Tanaka, N. K., Abuzeid, W. M., Civantos, A. M., Bezpalko, O., O'Malley, B. W., & Li, D. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0176 · Cited by 19
Harnacke, K., Kruhøffer, M., Orntoft, T. F., & Hass, R. (2005) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2005.08.009 · Cited by 19
Solution Structure of the DNA Binding Domain of Rice Telomere Binding Protein RTBP1,
Ko, S., Yu, E. Y., Shin, J. S., Yoo, H. H., Tanaka, T., Kim, W. T., Cho, H., Lee, W., & Chung, I. K. (2009) · Biochemistry · doi:10.1021/bi801270g · Cited by 19
“TRF1(1) negatively regulates telomere length by inhibiting the interaction between telomeres and telomerase (13), whereas TRF2, a paralog of TRF1, is required to protect chromosome ends (14) and stabilizes a terminal loop structure called the t-loop (15).”
BackgroundMus musculus and Mus spretus homologues of the human telomere-associated protein TIN2
Kim, S., Parrinello, S., Kim, J., & Campisi, J. (2003) · Genomics · doi:10.1016/s0888-7543(02)00033-2 · Cited by 19
PinX1: a sought-after major tumor suppressor at human chromosome 8p23
Zhou, X. Z. (2011) · Oncotarget · doi:10.18632/oncotarget.339 · Cited by 18
A role for sister telomere cohesion in telomere elongation by telomerase
Houghtaling, B. R., Canudas, S., & Smith, S. H. (2012) · Cell Cycle · doi:10.4161/cc.11.1.18633 · Cited by 21
AKT-dependent signaling of extracellular cues through telomeres impact on tumorigenesis
Sánchez-Vazquez, R., Martínez, P., & Blasco, M. A. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009410 · Cited by 19
“In addition, expression of dominantnegative mutants of TRF1 lead to telomere elongation [6], suggesting that TRF1 is a negative regulator of telomere elongation by telomerase.”
BackgroundResultInfluentialTelomerase‐based therapies in haematological malignancies
Rafat, A., Asl, K. D., Mazloumi, Z., Movassaghpour, A. A., Farahzadi, R., Nejati, B., & Charoudeh, H. N. (2022) · Cell Biochemistry and Function · doi:10.1002/cbf.3687 · Cited by 18
Maeda, T., Guan, J., Koyanagi, M., & Makino, N. (2012) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2012.00936.x · Cited by 18
The OB-fold domain 1 of human POT1 recognizes both telomeric and non-telomeric DNA motifs
Choi, K. H., Lakamp, A. S., Kolar, C., Yan, Y., Borgstahl, G. E. O., & Ouellette, M. M. (2015) · Biochimie · doi:10.1016/j.biochi.2015.04.015 · Cited by 18
Mezníková, M., Erdmann, N., Allsopp, R., & Harrington, L. A. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.004069 · Cited by 19
“…(Fauce et al., 2008)], perhaps combined with a partial and transient depletion of essential cis-inhibitory telomere factors such as TRF1 or TRF2 (van Steensel and de Lange, 1997; Smogorzewska et al., 2000; Karlseder et al., 2003), might shift the balance toward telomere maintenance or extension…”
InfluentialTelomere maintenance in interplay with DNA repair in pathogenesis and treatment of colorectal cancer
Tomášová, K., Kroupa, M., Försti, A., Vodička, P., & Vodičková, Ľ. (2020) · Mutagenesis · doi:10.1093/mutage/geaa005 · Cited by 23
Identification and Characterization of an Essential Telomeric Repeat Binding Factor in Fission Yeast
Pitt, C. W., Valente, L. P., Rhodes, D., & Simonsson, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708784200 · Cited by 18
Takata, M., Kerman, K., Nagatani, N., Konaka, H., Namiki, M., & Tamiya, E. (2006) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2006.07.025 · Cited by 19
Telomerase targeting in cancer treatment: new developments
Helder, M. N., de Jong, S., de Vries, E. G. E., & van der Zee, A. G. J. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0074 · Cited by 18
Muñoz‐Jordán, J. L., & Cross, G. A. (2001) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(01)00259-6 · Cited by 21
“FLAG-tagged TRF1 was detected by using the anti-FLAG monoclonal M2 (Sigma) or rabbit antibody 371 [6].”
BackgroundMethodInfluentialTelomere Length, Telomere-binding Proteins, and DNA Damage Signaling
HEMANN, M. T., HACKETT, J., IJPMA, A., & GREIDER, C. W. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.275 · Cited by 18
Yue, X., Tiwari, N. K., Zhu, L., Ngo, H. D. T., Lim, J., Gim, B., Jing, S., Wang, Y., Qian, Y., & Lee, I. (2021) · Communications Biology · doi:10.1038/s42003-021-02899-0 · Cited by 17
TRF1 and TRF2: pioneering targets in telomere-based cancer therapy
Kallingal, A., Krzemieniecki, R., Maciejewska, N., Brankiewicz, W., & Bagiński, M. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05867-3 · Cited by 20
“TRF1 binds to double-stranded telomeric DNA and negatively regulates telomerase access to telomeres, thereby controlling telomere length (van Steensel and de Lange 1997b).”
BackgroundLiu, W., Zhang, Y., Zhang, Z.-X., & Ding, J. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0030600 · Cited by 17
Elimination of Senescent Cells: Prospects According to the Subtelomere-Telomere Theory
Libertini, G., Ferrara, N., Rengo, G., & Corbi, G. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918120064 · Cited by 19
Yan, S., Song, L., Chen, K., Yin, S., Peng, H., Cai, N., Ma, W., Songyang, Z., & Huang, Y. Y. (2022) · Cells · doi:10.3390/cells11091485 · Cited by 17
“a telomerase-positive fibrosarcoma cell line that can maintain a constant telomere length during in vitro passaging, and is commonly used in the telomere field [32].”
BackgroundTsai, R. Y. L. (2009) · Cell Cycle · doi:10.4161/cc.8.18.9543 · Cited by 17
Coordinated Interactions of Multiple POT1-TPP1 Proteins with Telomere DNA
Corriveau, M., Mullins, M. R., Baus, D., Harris, M. E., & Taylor, D. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.471896 · Cited by 21
Ning, X., Yang, S., Wang, R., Zhang, R., Guo, L., Tie, J., Yongbo, C., Wang, G., Wan, S., & Fang, D.-C. (2010) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e32833b4812 · Cited by 17
Khadka, P., Lee, J. H., Baek, S. H., Oh, S. Y., & Chung, I. K. (2014) · Biochemical Journal · doi:10.1042/bj20131395 · Cited by 18
LIM Protein Ajuba Participates in the Repression of the ATR-Mediated DNA Damage Response
Kalan, S., Matveyenko, A., & Loayza, D. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00095 · Cited by 17
Gravel, C. (2003) · DNA repair · doi:10.1016/j.dnarep.2003.10.012 · Cited by 17
Desmaze, C., Pirzio, L. M., Blaise, R., Mondello, C., Giulotto, E., Murnane, J. P., & Sabatier, L. (2004) · Cytogenetic and Genome Research · doi:10.1159/000077476 · Cited by 17
Okabe, J., Eguchi, A., Wadhwa, R., Rakwal, R., Tsukinoki, R., Hayakawa, T., & Nakanishi, M. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddh032 · Cited by 17
“Interestingly, the upregulation of TRF1 was also independent of telomerase activity and of TR length (Fig. 1), suggesting that TRF1 may function independently of the proposed role in telomerase-dependent TR length regulation in immortal cells ( 14 ).”
BackgroundInfluentialA new insight into cell biological and biochemical changes through aging
Sahabi, S., Jafari-Gharabaghlou, D., & Zarghami, N. (2022) · Acta Histochemica · doi:10.1016/j.acthis.2021.151841 · Cited by 16
Deb, S., Berei, J., Miliavski, E., Khan, M. J., Broder, T. J., Akurugo, T. A., Lund, C., Fleming, S. E., Hillwig, R., Ross, J., et al. (2024) · Cells · doi:10.3390/cells13110884 · Cited by 17
“A study conducted on telomerase-positive tumor cells showed that overexpression of TRF1 led to the gradual shortening of telomeres, whereas deletion of TRF1 led to telomere elongation [14,15].”
BackgroundEffects of age and oligoasthenozoospermia on telomeres of sperm and blood cells
Balmori, C., Córdova-Oriz, I., Alba, G. D., Medrano, M., Jiménez-Tormo, L., Polonio, A. M., Chico-Sordo, L., Pacheco, A., García-Velasco, J. A., & Varela, E. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.10.010 · Cited by 18
Protection of internal (TTAGGG)n repeats in Chinese hamster cells by telomeric protein TRF1
Krutilina, R. I., Smirnova, A., Mudrak, O., Pleskach, N., Svetlova, M., Sl, O., Yau, P. M., Bradbury, E. M., Zalensky, A. O., & Tomilin, N. (2003) · Oncogene · doi:10.1038/sj.onc.1206745 · Cited by 20
Metadata
- Authors
- van Steensel, B., & de Lange, T.
- Venue
- Nature
- Published
- 1997-02
- Volume
- 385
- Issue
- 6618
- Pages
- 740-743
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2086992094
- Semantic Scholar
- 080771c5a8e8b8bc6d55561a31326094194412ea
- Cited by
- 1,219
- References
- 30
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 26 · 2023: 27 · 2022: 13 · 2021: 35 · 2020: 25 · 2019: 25 · 2018: 28 · 2017: 32 · 2016: 30 · 2015: 28 · 2014: 44 · 2013: 37 · 2012: 32
- FWCI
- 43.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- TRF1, telomere length regulation, telomerase, telomere shortening, telomere elongation, telomere binding, negative feedback loop, cancer cells, immortalized cells, TTAGGG repeats
- MeSH terms
- DNA-Binding Proteins, Feedback, Genes, Dominant, HeLa Cells, Humans, Mutation, Recombinant Proteins, Tumor Cells, Cultured, Telomere, Telomerase, Telomeric Repeat Binding Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.